Results
|
|
1.
|
|
|
|
2.
|
Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis". [electronic resource] by
- Tsivgoulis, Georgios
- Palaiodimou, Lina
- Katsanos, Aristeidis H
- Voumvourakis, Konstantinos
- Hadjigeorgiou, Georgios M
- Heliopoulos, Ioannis
- Karapanayiotides, Theodore
- Papathanasopoulos, Panagiotis
- Kilidireas, Constantinos
- Grigoriadis, Nikolaos
Producer: 20200213
In:
CNS drugs vol. 33
Availability: No items available.
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Reply to: Comment on Y.D. Fragoso et al.: "Lymphocyte count in peripheral blood is not associated with the level of clinical response to treatment with fingolimod" [Mult. Scler. Relat. Disord. (2017)]. [electronic resource] by
- Fragoso, Yara Dadalti
- Spelman, Tim
- Boz, Cavit
- Alroughani, Raed
- Lugaresi, Alessandra
- Vucic, Steve
- Butzkueven, Helmut
- Terzi, Murat
- Havrdova, Eva
- Horakova, Dana
- Granella, Franco
- Olascoaga, Javier
- Menoyo, José Luis Sánchez
- Pucci, Eugenio
- Barnett, Michael
- Brooks, Joseph Bruno B
- Haartsen, Jodi
Producer: 20181105
In:
Multiple sclerosis and related disorders vol. 22
Availability: No items available.
|
|
|
19.
|
|
|
|
20.
|
|